SCHEMBL5597893

SCHEMBL5597893

O=C(CI)Nc1ccc(Br)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.73
MEN1 O00255 3/20 0.73
HPGD P15428 2/20 0.59
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
HTT P42858 2/20 0.54
LMNA P02545 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
ALDH1A1 P00352 4/20 0.53
ALOX12 P18054 1/20 0.53
KDM4E B2RXH2 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAOA P21397 1/20 0.52
MAOB P27338 1/20 0.52
MAPT P10636 2/20 0.52
POLB P06746 2/20 0.50
F13A1 P00488 1/20 0.50
TGM2 P21980 1/20 0.50
TGM1 P22735 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21765862 0.89 MEN1 (0.54) KMT2AMEN1NPC1RAB9AHTT
SCHEMBL16140981 0.85 KMT2A (1.00) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL10852762 0.81 POLB (0.47) KMT2AMEN1POLB
SCHEMBL1039601 0.81 KMT2A (0.76) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL5271791 0.81 KMT2A (0.76) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL10865344 0.81 CYP1A1 (0.60) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL969565 0.79 KMT2A (0.73) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL7445670 0.79 KMT2A (0.73) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL14005147 0.79 POLB (0.73) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL7934465 0.79 KMT2A (0.73) KMT2AMEN1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-7119120-B2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2006-10-10 US disclosed
EP-1465638-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2004-10-13 EP disclosed
US-20040019113-A1 Phosphate transport inhibitors GELTEX PHARMACEUTICALS, INC. 2004-01-29 US disclosed
WO-2003057225-A2 PHOSPHATE TRANSPORT INHIBITORS GENZYME CORPORATION (US) 2003-07-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040019113-A1 Phosphate transport inhibitors SLC34A1, SLC34A2, SLC20A1 KMT2A 4536/4885MEN1 2905/4885HPGD 854/4885
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 KMT2A 4634/4885MEN1 2248/4885HPGD 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.